Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...
A Phase 2 clinical trial finds that ALT flares are common in hepatitis D patients treated with pegylated interferon-alpha, ...
Xie Qing, director of infectious diseases department at Ruijin Hospital, which is affiliated with Shanghai Jiao Tong ...
Large-scale data on the hepatitis D virus (HDV)/hepatitis B virus (HBV) co-infection rate is needed to estimate the current ...
There are many reasons why tourists consider visiting New Zealand. The island country — located in the southwestern Pacific ...
While acute hepatitis B infection is often resolved by the immune system, CHB occurs when the body's defences are unable to ...
Arbutus Biopharma restructures to cut costs & focus on Hepatitis B drug imdusiran. Read more about ABUS stock here.
Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...
The hepatitis A virus (HAV) is one of the main causes of viral hepatitis and is responsible for an estimated 159,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback